MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of a retrospective analysis of real-world data in the Journal of Comparative Effectiveness Research (JCER). The study ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

An expansion of a hexanucleotide repeat in the C9ORF72 gene can cause ALS. Here, the authors develop a high-fidelity RNA-targeting CRISPR system to suppress the repeat RNA expressed from the ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...

Dozens of people in one North Carolina family all have amyotrophic lateral sclerosis, a deadly disease ... Only five-to-10% of people with ALS in the U.S. have a family member with the disease.

Hawking authored numerous books throughout his career and gave guest lectures around the world despite being paralyzed from amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s ...

Moshe Nussbaum, 71, a longtime reporter for Israel's Channel 12 news, was diagnosed two years ago with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The condition ...

targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.